Assignee
LIPOXEN TECH LIMITED
GB·9 granted patents·8 pending applications·0 citations·filing 2015–2022
Top patents by PatentIndex Score
17 records- 0174US2022133898A1Derivatisation of Insulin with PolysaccharidesLIPOXEN TECH LIMITED·Filed 2022·Application pending·0 cites
- 0273US10494449B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2017·Granted Dec 3, 2019·0 cites·5 claims
- 0367US10155046B2Activated sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2015·Granted Dec 18, 2018·0 cites·35 claims
- 0466US10301396B2Reduction of endotoxin in polysialic acidsLIPOXEN TECH LIMITED·Filed 2015·Granted May 28, 2019·0 cites·25 claims
- 0566US2021401999A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 0666US2019216938A1Derivatisation of Insulin with PolysaccharidesLIPOXEN TECH LIMITED·Filed 2019·Application pending·0 cites
- 0765US10155045B2Activated sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2015·Granted Dec 18, 2018·0 cites·49 claims
- 0865US9920137B2Polysialic acid derivativesLIPOXEN TECH LIMITED·Filed 2015·Granted Mar 20, 2018·0 cites·14 claims
- 0965US2022008544A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 1063US10772968B2Glycopolysialylation of non-blood coagulation proteinsLIPOXEN TECH LIMITED·Filed 2017·Granted Sep 15, 2020·0 cites·2 claims
- 1162US9828443B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2015·Granted Nov 28, 2017·0 cites·34 claims
- 1262US2018289823A1N-Terminal PolysialylationLIPOXEN TECH LIMITED·Filed 2017·Application pending·0 cites
- 1359US2019083636A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 1458US10406209B2Sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2016·Granted Sep 10, 2019·0 cites·6 claims
- 1550US2020179524A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 1646US2022023430A1Glycopolysialylation of blinatumomabLIPOXEN TECH LIMITED·Filed 2019·Application pending·0 cites
- 1745US10406150B2Method for treatment of primary hormone resistant endometrial and breast cancersLIPOXEN TECH LIMITED·Filed 2017·Granted Sep 10, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when LIPOXEN TECH LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →